BEYOND: betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is to determine * whether treatment with Betaferon / Betaseron (interferon beta-1b) 500 micrograms safe, tolerable and more efficacious than treatment with interferon beta-1b 250 micrograms * whether treatment with Betaferon / Betaseron (interferon beta-1b) tolerable and more efficacious than treatment with Copaxone (Glatiramer Acetate) 20 mg
Epistemonikos ID: f331ee6af7011bb17770b66a2489622acec90b70
First added on: Sep 11, 2014